Slingshot Insights | Insy Overview

INSY Overview

Upcoming Projects (INSY)

Don’t see a project related to the company you care about? Create your own!

Executed Projects (INSY)

Don’t see a project related to the company you care about? Create your own!

Upcoming & Overdue Catalysts (INSY)

Don’t see a catalyst related to the company you care about? Create your own!

Occurred Catalysts (INSY)

FDA Grants INSYS Therapeutics ‘Fast Track’ Designation for Cannabidiol (CBD) Oral Solution as Investigational Treatment for Prader-Willi Syndrome
Ticker: INSY
Occurred on: Dec 26, 2017
Insys Therapeutics Reports Phase 3 Trial of Sublingual Buprenorphine Spray Met Primary Endpoint in Patients with Moderate-to-Severe Postoperative Pain after Bunionectomy
Ticker: INSY
Occurred on: Aug 24, 2016
PDUFA April 1 2016 of Dronabinol Oral Solution for AIDS-related anorexia
Ticker: INSY
Occurred on: Jul 05, 2016
Insys Therapeutics, Inc. Announces 3-Month Extension of PDUFA Date for Syndros (dronabinol oral solution) from April 1, 2016 until July 1, 2016
Ticker: INSY
Occurred on: Jul 05, 2016
Insys Therapeutics Announces FDA Approval of Syndros
Ticker: INSY
Occurred on: Jul 05, 2016
Insys Therapeutics Enrolls First Patient in Phase II Study for the Treatment of Infantile Spasms Using Pharmaceutical CBD
Ticker: INSY
Occurred on: Feb 09, 2016

Strategic Initiatives (INSY)

Don’t see a strategic initiative related to the company you care about? Create your own!